Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Rotavac probably leads to lower severe cases of all‐cause diarrhoea compared with placebo (moderate certainty).
It is very uncertain whether rotavac changes all‐cause death compared with placebo (very low certainty).
Rotavac showed no clear difference in all serious adverse events compared with placebo (moderate certainty).
It is very uncertain whether rotavac changes serious adverse events: intussusception compared with placebo (very low certainty).
It is very uncertain whether fluoxetine changes response (> 50% improvement on 29‐item HAM‐D SIGH‐SAD) compared with placebo (very low certainty).
It is very uncertain whether fluoxetine changes remission (response plus end score 8 or less) compared with light therapy (very low certainty).
The review found no eligible studies for this question.
Fluoxetine showed no clear difference in adverse events (at least 1 treatment‐emergent adverse event) compared with light therapy (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether fluoxetine changes overall adverse events 5 weeks compared with placebo (very low certainty).
Fluoxetine showed no clear difference in response (> 50% improvement on 24‐item HAM‐D SIGH‐SAD) compared with light therapy (low certainty).
Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
Dopamine agonist plus co‐intervention showed no clear difference in miscarriage rate compared with co‐intervention (low certainty).
It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in miscarriage rate compared with other active intervention (low certainty).